WASHINGTON, D.C. – Following the release by the Centers for Medicare and Medicaid Services (CMS) of a reimbursement rate of $42.13 for the most commonly-performed ... Read More
WASHINGTON, D.C. — Following the introduction of the ‘‘Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act” ACLA President Julie Khani issued the following statement: “ACLA is currently ... Read More
WASHINGTON, D.C. — Following the Trump Administration’s announcements today on expanding access to testing, ACLA President Julie Khani released the following statement: “After scaling up to meet an ... Read More
WASHINGTON, D.C. — Following ongoing developments related to COVID-19 testing and response, ACLA President Julie Khani issued the following statement: “Labs are not scaling back. We’re ramping ... Read More
WASHINGTON, D.C. – Following the revised policy on serologic testing announced today by the Food and Drug Administration, ACLA President Julie Khani issued the following ... Read More
WASHINGTON, D.C. – Following today’s meeting at the White House, ACLA President Julie Khani issued the following statement: “ACLA appreciated the opportunity to meet today ... Read More
WASHINGTON, D.C. — Following Senate passage of the Paycheck Protection Program and Health Care Enhancement Act, ACLA President Julie Khani released the following statement: ACLA ... Read More
Federal Funding Is Needed To Ensure Laboratories Can Scale High Throughput Testing For COVID-19 Washington, D.C. – The American Clinical Laboratory Association is encouraged by ... Read More
WASHINGTON, D.C. — The American Clinical Laboratory Association (ACLA) today announced Dave King, former CEO of Laboratory Corporation of America Holdings (LabCorp), will join ACLA as ... Read More
Association announces plans to highlight members’ efforts during Laboratory Professionals Week (April 19 – 25) WASHINGTON, D.C. — Today, the American Clinical Laboratory Association (ACLA) ... Read More
